Associate Director, Manufacturing Operations
Peter Gelinas is the Associate Director of Manufacturing Operations for ElevateBio. Peter has worked in the Gene and Cell Therapy space for over 10 years and has significant experience in manufacturing and CMC product development.
Prior to joining ElevateBio Peter was at bluebird bio for 4 plus years leading both the Drug Product MS&T group and CMC team for the Lenti-D Gene Therapy program for the Treatment of Cerebral Adrenoleukodystrophy (CALD). In his MS&T role he completed multiple late phase global technology transfers and led the drug product process validation efforts instrumental to filing the Marketing Authorization Application (MAA) for Zynteglo. Previously Peter worked in various roles at the Connell O’Reilly Cell Manipulation Core Facility (CMCF) at Dana Farber Cancer Institute (DFCI) assisting in development and manufacturing of gene and cell based therapies for conditions such as melanoma, MDS/AML, ALS, SCID-X1, and Wiskott Aldrich Syndrome (WAS). Peter received his bachelor’s degree in Biology from Springfield College.